What You'll Want to Know About ImmunoGen's Q2 Results

There wasn't much to be thrilled about the last time ImmunoGen (NASDAQ: IMGN) announced its quarterly results in May. Revenue decreased. The biotech's net loss worsened.

But that's old news. ImmunoGen announced its second-quarter results after the market opened on Friday. It was a much different story this time around. Here are the highlights from the company's Q2 update.

Image source: Getty Images

Continue reading

Quelle Fool.com